Form 4 for PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Accepted 2022-04-13 00:00:00 ET · period of report 2021-02-12 · accession 0000899243-22-014756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-04-13 | 2021-02-12+ | PACB | Ericson William W. | Dir | J - Other | — | +1,336 | 1,336 | New | — |
| MI | 2022-04-13 | 2021-02-12+ | PACB | Ericson William W. | Dir | J - Other | — | -5.60M | 4.85M | -54% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-02-12 | J | A | 68 | — | 68 | D MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP | — | — | (F1) Distribution in kind from MDV VII Leaders' Fund, L.P. and MDV VII, L.P. without consideration to their partners. (F4) Shares are directly held by William Ericson, and were received pursuant to the in-kind distribution without consideration by MDV VII Leaders' Fund, L.P. and MDV VII, L.P. to their partners. (F3) Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P. and (v) MDV VII Leaders' Fund, L.P. (the "MDV VII Funds") and has sole voting and investment power over the shares. William Ericson is a Managing director with Mohr Davidow Ventures, but is not a Managing Member of Seventh MDV Partners, LLC, however he may be deemed to indirectly beneficially own the shares affiliated with the MDV VII Funds. Mr. Ericson disclaims beneficial ownership of the shares held by the MDV VII Funds except to the extent of any pecuniary interest therein. |
| 2 | Common | Common Stock | 2022-03-17 | J | D | 4,848,397 | — | 0 | I | — | — | (F5) Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners. |
| 3 | Common | Common Stock | 2021-02-12 | J | D | 750,000 | — | 4,848,397 | I MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP | — | — | (F1) Distribution in kind from MDV VII Leaders' Fund, L.P. and MDV VII, L.P. without consideration to their partners. (F2) These shares were inadvertently omitted as a holding on a Form 4 filed on June 21, 2021. (F3) Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P. and (v) MDV VII Leaders' Fund, L.P. (the "MDV VII Funds") and has sole voting and investment power over the shares. William Ericson is a Managing director with Mohr Davidow Ventures, but is not a Managing Member of Seventh MDV Partners, LLC, however he may be deemed to indirectly beneficially own the shares affiliated with the MDV VII Funds. Mr. Ericson disclaims beneficial ownership of the shares held by the MDV VII Funds except to the extent of any pecuniary interest therein. |
| 4 | Common | Common Stock | 2022-03-17 | J | A | 1,268 | — | 1,336 | D | — | — | (F5) Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners. (F6) Shares are directly held by William Ericson, and were received pursuant to the in-kind distribution without consideration by MDV VII Leaders' Fund, L.P. to its partners. |